Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Pertussis Vaccine Market Evolve in Terms of Growth and Size by 2029?

In recent times, the market for the pertussis vaccine has seen consistent growth. The market is projected to increase from $5.5 billion in 2024 to $5.65 billion in 2025, expanding at a compound annual growth rate (CAGR) of 2.9%. The historical growth has been driven by factors such as disease prevalence, immunization schemes, pediatric vaccinations, and regulatory approvals.

The market for the pertussis vaccine is anticipated to experience consistent expansion in the coming years, with projections predicting its growth to “$6.49 billion in 2029, boasting a compound annual growth rate (CAGR) of 3.5%. The projected growth in this timeframe can be connected to factors such as booster vaccination, maternal immunization, immunization of healthcare workers, and global health initiatives. Key trends anticipated for the forecast period are personalized immunization schedules, combination vaccines, initiatives for the equitable distribution of vaccines, and the application of digital health technology in immunization processes.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

What factors are expected to fuel Pertussis Vaccine market growth in the coming years?

The escalation in birth rates is fueling the expansion of the pertussis vaccine market. Giving birth to a child, also known as childbirth, symbolizes the start of an independent life for the child outside the mother’s womb, after being developed in the uterus. The main usage of the pertussis vaccine is in newborns as it guards against whooping cough and other serious or potentially lethal illnesses. For example, the Centers for Disease Control and Prevention, a national public health organization based in the US, reported in January 2023 that there was a surge of 1% in recorded births, amounting to 3,664,292, compared to the preceding year. Consequently, the surging birth rates are propelling the pertussis vaccine market’s development.

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

What Trends Are Currently Influencing Growth In The Pertussis Vaccine Market?

Leading firms in the pertussis vaccine market are creating novel medicines and gaining regulatory approvals to maintain their market presence. For example, GSK plc., a pharma and biotech company based in the UK, revealed in October 2022 that the U.S. Food and Drug Administration (FDA) had approved BOOSTRIX. This vaccine, which is an adsorbed tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine, is administered during pregnancy to protect newborns from contracting pertussis, also known as whooping cough. It is given via a single injection into the upper arm muscle. Boostrix has been proven safe and efficient for expectant women and their newborns, with a successful track record in preventing pertussis, even its severe forms.

What Are The Most Active Companies In The Pertussis Vaccine Market Today?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Regional Markets Are Attracting The Most Investment In Pertussis Vaccine?

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model